A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab

A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab

Abstract Pulmonary pleomorphic carcinoma is often refractory to chemotherapy and follows an aggressive clinical course. Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced lung cancer, and a few cases with pleomorphic carcinoma have been reported to show tumor shrinkage...

Full description

Bibliographic Details
Main Authors: Masahiro Sako, Hiroshi Nokihara, Kensuke Kondo, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Akane Abe, Hiroto Yoneda, Hirokazu Ogino, Kenji Otsuka, Hisanori Uehara, Yasuhiko Nishioka
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Thoracic Cancer
Subjects:
interstitial pneumonia
pembrolizumab
pulmonary pleomorphic carcinoma
Online Access:https://doi.org/10.1111/1759-7714.14243

Internet

https://doi.org/10.1111/1759-7714.14243

Similar Items